Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. TVGN
TVGN logo

TVGN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Tevogen Bio Holdings Inc (TVGN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
7.000
1 Day change
-26.62%
52 Week Range
71.000
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Tevogen Bio Holdings Inc (TVGN) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The technical indicators suggest a bearish trend, with no positive trading signals or catalysts. Additionally, there is no recent news, financial data, or analyst ratings to support a buy decision. The stock's projected performance over the next month shows a high probability of further decline, making it unsuitable for long-term investment at this time.

Technical Analysis

The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 43.815, and moving averages are converging, showing no clear trend. Key support is at 9.424, and the stock is trading close to this level, with resistance levels significantly higher. Overall, the technical indicators suggest a bearish trend.

Positive Catalysts

  • NULL identified. No recent news or events to act as a positive catalyst.

Neutral/Negative Catalysts

  • Bearish technical indicators and a high probability of price decline (-17.87% in the next month). No recent news, financial data, or significant trading trends to support the stock.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst ratings or price target changes available.

Wall Street analysts forecast TVGN stock price to rise
Analyst Rating
0
Wall Street analysts forecast TVGN stock price to rise
Buy
Hold
Sell
0
Current: 9.540
sliders
Low
0
Averages
0
High
0
0
Current: 9.540
sliders
Low
0
Averages
0
High
0
Boral Capital
D. Boral
Buy -> Hold
downgrade
AI Analysis
2026-03-04
Reason
Boral Capital
D. Boral
Price Target
AI Analysis
2026-03-04
downgrade
Buy -> Hold
Reason
D. Boral Capital downgraded Tevogen to Hold from Buy without a price target citing the company's 50:1 reverse stock split. While the move is largely technical in nature, reverse stock splits are often perceived negatively by the market, and historically, stocks tend to trade lower following such events, the analyst tells investors in a research note. D. Boral believes the split will add additional near-term trading pressure and reflects Tevogen's weaker capital markets position.

People Also Watch